State of the Art: Concise ReviewTargeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer
Under a Creative Commons license
open access
Key Words
Anaplastic lymphoma kinase
Brain metastases
Epidermal growth factor receptor
Non–small-cell lung cancer
Targeted therapy
Cited by (0)
Disclosure: Dr. Baik served on an advisory board for Novartis. Dr. Chamberlain serves on an advisory board for Genentech/Roche and Novartis. Dr. Chow served on advisory boards for Merck and Novartis.
Copyright © 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc.